KLF9 Recombinant antibody

KLF9 {ptg:Brand} Recombinant Antibody for WB, FC (Intra), ELISA
Cat No. 83183-4-RR
Clone No.230436H2

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

WB, FC (Intra), ELISA

GC-box-binding protein 1, BTE-binding protein 1, BTEB1, BTEB, Basic transcription element-binding protein 1

Formulation:  PBS and Azide
PBS and Azide
PBS Only
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Tested Applications

Positive WB detected inHeLa cells, K-562 cells, HepG2 cells, A549 cells, U2OS cells
Positive FC (Intra) detected inA549 cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:5000-1:50000
Flow Cytometry (FC) (INTRA)FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

83183-4-RR targets KLF9 in WB, FC (Intra), ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Host / Isotype Rabbit / IgG
Class Recombinant
Type Antibody
Immunogen KLF9 fusion protein Ag34411 Predict reactive species
Full Name Kruppel-like factor 9
Calculated Molecular Weight27 kDa
Observed Molecular Weight27-35 kDa
GenBank Accession NumberBC074880
Gene Symbol KLF9
Gene ID (NCBI) 687
RRIDAB_3670873
Conjugate Unconjugated
Form Liquid
Purification MethodProtein A purification
UNIPROT IDQ13886
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol , pH 7.3
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

Krüppel-like factor 9 (KLF9) was a member of SP/KLF family of DNA-binding transcriptional regulators featured by a highly homologous C-terminal three C2H2-type zinc finger DNA-binding domains. KLF9 has been previously reported to be downregulated in various types of human malignancy and serves as a tumour suppressor at tumour onset and development, affecting cell proliferation, apoptosis, metastasis and tumorigenicity (PMID: 32855660).

Protocols

Product Specific Protocols
WB protocol for KLF9 antibody 83183-4-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...